「in vitroinvivo」の検索結果
165件：121～125件目を表示
-
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
和田智之、尾松和則 もっと見る 海外 ARVO 2026 開催日：2026年5月３日～2026年5月7日 開催地：Denver, Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendrit...
https://www.senju.co.jp/rd/society/ -
r 22, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel ...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
r 22, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel ...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
Mytear HARD LENS WETTING SOLUTION | OTC Products, etc. | Products | SENJU Pharmaceutical
Designated quasi-drugs Mytear® HARD LENS WETTING SOLUTION Lubricates lenses, allows smooth insertion CHARACTERISTICS Viscous liquid forms a thin layer on the surface of hard or rigid gas permeable len...
https://www.senju.co.jp/english/products/wettingsolution.html -
Mytear HARD LENS WETTING SOLUTION | OTC Products, etc. | Products | SENJU Pharmaceutical
Designated quasi-drugs Mytear® HARD LENS WETTING SOLUTION Lubricates lenses, allows smooth insertion CHARACTERISTICS Viscous liquid forms a thin layer on the surface of hard or rigid gas permeable len...
http://www.senju.co.jp/english/products/wettingsolution.html